Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avantius Group is a private U.S.-based investment holding and product platform company focused on science-backed proactive wellness and consumer health products. Its portfolio centers on ophthalmic and brain health offerings, including MacuHealth eye-health supplements, Memory Health/ReMind cognitive products, and Natura Medica products such as VitreousHealth and TG Omega-3. The company positions itself around peer-reviewed evidence, patentable or patented formulations, and commercialization of preventive rather than curative solutions. In addition to marketed products, Avantius operates an incubator for earlier innovations and participates in IP-oriented ventures such as Maravilla. Overall, it is better characterized as a nutraceutical/consumer-health platform than a traditional drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avantius Group.